全球血管造影術設備市場:市場規模，市場佔有率，市場分析 - 各產品、技術、用途、終端用戶、地區 - 成長率，趨勢，預測(2018年∼2023年)

全球血管造影術設備市場，預計從2018年到2023年以4.5％的年複合成長率發展。由於心血管疾病的盛行率上升，先進血管造影術設備的認證，政府及公私合營的投資增加，啟發活動的增加，血管造影術設備的引進數增加等成為這個市場主要成長要素。

本報告提供全球血管造影術設備市場調查，市場概要，各產品、技術、用途、終端用戶、地區的市場規模的變化與預測，市場趨勢，市場成長要素及阻礙因素分析，市場機會，競爭情形，主要企業的簡介等全面性資訊。

目錄

第1章 簡介

• 市場定義

第2章 調查方法

第3章 摘要整理

第4章 主要影響要素

第5章 血管造影術設備市場概要

• 目前市場方案
• 波特的五力分析
  • 買方議價能力
  • 供給企業談判力
  • 新加入業者的威脅
  • 替代品的威脅
  • 競爭企業間的敵對關係

第6章 市場趨勢

• 市場成長要素
  • 非冠動脈攝影術實施數量的增加
  • 心臟血管疾病的發生率的上升
  • 由於啟發活動的血管造影術市場推動
  • 重要的產品的銷售
• 市場阻礙因素
  • 血管造影術相關的風險
  • 重大的產品回收
• 市場機會
• 主要課題

第7章 全球血管造影術設備市場:各市場區隔

• 各產品
  • 血管造影術系統
  • 消耗品
• 各技術
  • MRI
  • CT
  • X光掃描
  • 其他
• 各用途
  • 大腦
  • 頸動脈
  • 末梢血管
  • 主動脈
  • 冠狀動脈
  • 其他
• 各終端用戶
  • 醫院
  • 診斷中心
  • 門診外科中心
  • 其他
• 各地區
  • 北美
  • 歐洲
  • 亞太地區
  • 中東、非洲地區
  • 南美

第8章 企業簡介和競爭情形

• AngioDynamics, Inc.
• Boston Scientific Corporation
• Cordis Corporation
• GE Healthcare
• Abbott
• Medtronic PLC
• Philips N.V
• 島津製作所
• Siemens Healthcare

第9章 市場未來展望

The cardiovascular diseases which include heart attacks, strokes, and other circulatory diseases have become the leading cause of premature deaths. According to the World Health Organization, 2017, cardiovascular diseases account for nearly 17.9 million deaths per year, and this number is expected to grow to more than 23.6 million by 2030. Hence, the increasing number of cardiovascular diseases is driving the demand for angiography devices, which may ultimately result in the growth of the angiography devices market. Furthermore, other factors, such as rapid technological advances, increasing awareness of the population, and a high preference for minimally invasive procedures, are supplementing the market growth.

Key Market Trends

The Hospital Segment is Expected to Dominate the Market During the Forecast Period

The main factors attributing to the dominance of the hospital segment are the availability of the larger patient pool, high resource availability, high penetration in diverse geographical locations, availability of accompanying healthcare infrastructure and procedures, availability of skilled labor, and affordability via government funding. A large number of complex cardiac disease cases are on the rise, with the growth in the number of deaths due to cardiovascular diseases, across both the developed and emerging markets. The high accessibility and affordability of hospitals, as compared to the specialty clinics, attract a large patient population suffering from cardiovascular diseases. The profitability index of hospitals also increases, as they benefit from the bulk purchase discounts and trade agreements with the manufacturers and suppliers. Furthermore, these trade agreements open new avenues to timely upgradation and early access to technologically advanced products by the manufacturers, enhancing the hospital's treatment capability.

North America Dominates the Angiography Devices Market

North America dominates the angiography devices market, owing to the high adoption rate of minimally invasive procedures, availability of reimbursements, rising geriatric population, and high replacement rates of medical equipment. Factors, such as a good network of medical device companies and a large number of hospitals across cities and states with good funding opportunities, primarily help the region dominate the market. Furthermore, good support from government facilities helps in the development required for the overall treatment of cardiovascular diseases in the healthcare sector of the region.

Europe is the second-largest market after North America. The significant share of the European countries can be attributed to the high prevalence of cardiovascular diseases, high government investments, faster product approval procedures, and rising adoption of angiography devices due to a large number of angiography screening procedures being performed.

Competitive Landscape

The angiography devices market is consolidated and highly competitive. A few global players dominate the market, primarily due to the stringent product approval process, along with the need for significant technological capabilities. The key market players include AngioDynamics Inc., Boston Scientific Corporation, Canon Medical Systems Corporation, Cardinal Health Inc., GE Healthcare, Medtronic PLC, Koninklijke Philips NV, Shimadzu Corporation, Siemens Healthineers AG, and Terumo Corporation.

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 Study Deliverables
• 1.2 Study Assumptions
• 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

• 4.1 Market Overview
• 4.2 Market Drivers
  • 4.2.1 Rising Geriatric Population and Increasing Prevalence of Cardiovascular Diseases
  • 4.2.2 Growing Demand for Interventional Angiography in Minimally Invasive Surgeries
• 4.3 Market Restraints
  • 4.3.1 High Procedure and Equipment Cost
  • 4.3.2 Risks Associated with Angiography Procedures
• 4.4 Porter's Five Forces Analysis
  • 4.4.1 Threat of New Entrants
  • 4.4.2 Bargaining Power of Buyers/Consumers
  • 4.4.3 Bargaining Power of Suppliers
  • 4.4.4 Threat of Substitute Products
  • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

• 5.1 By Product
  • 5.1.1 Angiographic Systems
  • 5.1.2 Consumables
    • 5.1.2.1 Catheters
    • 5.1.2.2 Guidewires
    • 5.1.2.3 Contrast Media
    • 5.1.2.4 Incision Closure Devices
    • 5.1.2.5 Accessories
• 5.2 By Technology
  • 5.2.1 MRI
  • 5.2.2 CT
  • 5.2.3 X-ray
  • 5.2.4 Other Technologies
• 5.3 By Application
  • 5.3.1 Cerebral
  • 5.3.2 Carotid
  • 5.3.3 Peripheral
  • 5.3.4 Aortic
  • 5.3.5 Coronary
  • 5.3.6 Other Applications
• 5.4 By End User
  • 5.4.1 Hospitals
  • 5.4.2 Diagnostic Centers
  • 5.4.3 Ambulatory Surgical Centers
• 5.5 Geography
  • 5.5.1 North America
    • 5.5.1.1 United States
    • 5.5.1.2 Canada
    • 5.5.1.3 Mexico
  • 5.5.2 Europe
    • 5.5.2.1 Germany
    • 5.5.2.2 United Kingdom
    • 5.5.2.3 France
    • 5.5.2.4 Italy
    • 5.5.2.5 Spain
    • 5.5.2.6 Rest of Europe
  • 5.5.3 Asia-Pacific
    • 5.5.3.1 China
    • 5.5.3.2 Japan
    • 5.5.3.3 India
    • 5.5.3.4 Australia
    • 5.5.3.5 South Korea
    • 5.5.3.6 Rest of Asia-Pacific
  • 5.5.4 Middle-East and Africa
    • 5.5.4.1 GCC
    • 5.5.4.2 South Africa
    • 5.5.4.3 Rest of Middle-East and Africa
  • 5.5.5 South America
    • 5.5.5.1 Brazil
    • 5.5.5.2 Argentina
    • 5.5.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

• 6.1 Company Profiles
  • 6.1.1 AngioDynamics Inc.
  • 6.1.2 Boston Scientific Corporation
  • 6.1.3 Abbott Laboratories
  • 6.1.4 Cardinal Health Inc.
  • 6.1.5 GE Healthcare
  • 6.1.6 Medtronic PLC
  • 6.1.7 Koninklijke Philips NV
  • 6.1.8 Shimadzu Corporation
  • 6.1.9 Siemens Healthineers AG
  • 6.1.10 Terumo Corporation

7 MARKET OPPORTUNITIES AND FUTURE TRENDS